Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant RSV vaccines

Recombinant RSV vaccines

US Patent 9492531 · Granted Nov 15, 2016

Estimated economic value: $16,018,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins and combination vaccines comprising Haemophilus influenzae Prote2021
UspA2 protein constructs and uses thereof2021
UspA2 protein constructs and uses thereof2020
Fusion proteins and combination vaccines comprising haemophilus influenzae Prote2020
Immunogenic rhinovirus peptides2019
Fusion proteins and combination vaccines comprising Haemophilus influenzae prote2019
Vaccine2018
UspA2 protein constructs and uses thereof2018
Fusion proteins and combination vaccines comprising Haemophilus influenzae Prote2018
Expression system2018
Expression system2016
Fusion proteins and combination vaccines comprising Haemophilus influenzae Prote2016